Purple Biotech Ltd. ( PPBT) - Key Metrics
PPBT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | $0 | -$18.51 | -$671.58 | -$671.58 |
| 2025Q4 | $0 | -$9,870.61 | -$444.53 | -$445.78 |
| 2025Q3 | $0 | -$4.58 | -$3.75 | -$3.74 |
| 2025Q2 | $0 | -$3.96 | -$5.64 | -$5.65 |
| 2025Q1 | $0 | -$1.72 | -$7.51 | -$7.51 |
PPBT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | 0% | -0.05 |
| 2025Q4 | 0% | 0.00 |
| 2025Q3 | 0% | -0.04 |
| 2025Q2 | 0% | -1.47 |
| 2025Q1 | 0% | -3.69 |
PPBT
Price: $1.08
52 week price:
Earnings Per Share: -53.20 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 20300
Market Capitalization: 208507